← Back to headlines
Argus Turns Bullish on Pfizer, Highlights GLP-1 and Oncology Pipeline
Argus adopts a bullish stance on Pfizer, emphasizing the company's GLP-1 and oncology pipeline developments.
5 Mar, 01:55 — 5 Mar, 01:55
ℹOnly 1 source covers this story
